Premenstrual syndrome: Documentation by a linear analog scale compared with two descriptive scales

Casper, Robert F.; Powell, Anne-Marie

doi:10.1016/s0002-9378(86)80040-0

Cited by 41 publications

(17 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The main efficacy variable prospectively sought in the protocol was change from baseline to end point in the combined scores of the six self assessment items (irritability, mood alteration, anger, headache, other menstrual symptoms including bloating, and breast fullness). Women rated each item using a visual analogue scale25 validated for the assessment of the premenstrual syndrome, ranging from 0 (no symptoms) to 10 (unbearable), measured in millimetres on the linear scale. We chose the scale because it was validated and also because it correlates closely with other more complex tools and is a rapid and straightforward assessment of effect for use in community practice.…”

Section: Methodsmentioning

confidence: 99%

Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study

Schellenberg¹

2001

BMJ

245

110

View full text Add to dashboard Cite

trials. We conclude that electrodermal testing cannot diagnose allergy to common aeroallergens such as cat dander and house dust mite-allergens that have a strong association with atopic respiratory disorders such as asthma, rhinitis, eczema, and conjunctivitis.We thank Jackie Burnham for her help in preparing the manuscript, all the volunteers and the operators who gave up their time so willingly, and the doctors and practice manager at Hythe Medical Centre who made space and time available to us.Contributors: GTL, JNK, and STH conceived the study, developed the protocol, and obtained funding. JB was the trial manager. JG was responsible for the statistical design and randomisation, and PP for the analysis. All authors were jointly involved in writing the paper. STH will act as guarantor.Funding: The study was supported by funding from Vega Grieshaber, the Asthma Allergy and Inflammation Research Trust, and the Foundation for Integrated Medicine.Competing interests: GTL and JNK formerly had interests in a company involved in the distribution of Vega Grieshaber products and both have received fees for speaking at a seminar on the Vegatest. Results Improvement in the main variable was greater in the active group compared with placebo group (P < 0.001). Analysis of the secondary variables showed significant (P < 0.001) superiority of active treatment in each of the three global impression items. Responder rates were 52% and 24% for active and placebo, respectively. Seven women reported mild adverse events (four active; three placebo), none of which caused discontinuation of treatment. Conclusions Dry extract of agnus castus fruit is an effective and well tolerated treatment for the relief of symptoms of the premenstrual syndrome.

show abstract

Section: Methodsmentioning

confidence: 99%

Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study

Schellenberg¹

2001

BMJ

245

110

View full text Add to dashboard Cite

show abstract

“…After informed consent was obtained, and before endometrial ablation was performed, the women evaluated the perceived severity of 6 premenstrual symptoms using 6 VASs, previously validated in a similar population [17], where a score of 0 represented an absence of symptoms and 10 represented the strongest imaginable intensity. They were instructed to fill out the VAS to reflect the greatest intensity of symptoms experienced in the 14 days before to their last menstruation.…”

Section: Methodsmentioning

confidence: 99%

“…For each of the symptoms studied, the fourth quartile was used to discriminate between severe and mild cases. Selected premenstrual symptoms were irritability, agitation/anxiety, depression/sadness, headache, swelling/bloating, and breast tenderness [17,18]. In addition, participants were asked to fill out a short survey about the presence, duration, and amount of menstrual bleeding to determine whether the endometrial ablation procedure was successful for treating the bleeding.…”

Section: Methodsmentioning

confidence: 99%

Effect of Endometrial Ablation on Premenstrual Symptoms

Waddell

Pelletier

Desindes

et al. 2015

Journal of Minimally Invasive Gynecology

View full text Add to dashboard Cite

“…The diagnosis of PMS was based on prospective confirmation of the presence of luteal phase emotional and physical symptoms which resolved before the end of menses and occurred in at least two subsequent cycles. The symptom rating scales used by the referring physicians included the Self Rating Scale for Premenstrual Tension Syndrome , the Prospective Record of the Impact and Severity of Menstrual Symptomatology (PRISM) calendar (Reid, 1985), and a visual linear analogue scale (Casper & Powell, 1986).…”

Section: Subjectsmentioning

confidence: 99%

Pulsatile LH secretion in women with premenstrual syndrome (PMS): Evidence for normal neuroregulation of the menstrual cycle

Reame

Marshall

Kelch

1992

Psychoneuroendocrinology

View full text Add to dashboard Cite

SUMMARYThe premenstrual syndrome (PMS) has been proposed to result from excessive exposure to and/or withdrawal of brain opioid activity during the luteal phase. Because hypothalamic opioids are believed to modulate GnRH secretion, in part under the influence of ovarian steroids, we performed longitudinal studies of gonadotropin and ovarian steroid secretion across ovulatory, symptomatic cycles of 17 PMS patients and 8 normal volunteers. Pulsatile LH secretion was measured every 10 min for 8 hr at times when central opioid activity was expected to be low (early follicular phase), high (mid-luteal phase; ML), and declining (late luteal phase). In both subject groups, a cycle-phase effect was observed for LH pulse frequency (p =<0.001) and amplitude (p =0.002), and for the transverse mean concentrations of LH (p =0.05), FSH (p <= 0.001), estradiol (E2) (p=<0.001) and progesterone (P) (p =<0.001). ML P secretion in PMS patients was pulsatile, and mean concentrations (over 30-60 min) were similar to those of normal controls. The changes in pulsatile LH secretion across the cycle were not different in the PMS patients compared to the normal women, though mean FSH in the ML phase was higher in the PMS group (p =<0.05). The similar changes in luteal LH pulse frequency fail to provide evidence that GnRH secretion is impaired, thus challenging the view that the neuroregulation of the menstrual cycle in women with PMS is markedly altered.

show abstract

Premenstrual syndrome: Documentation by a linear analog scale compared with two descriptive scales

Cited by 41 publications

References 5 publications

Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study

Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study

Effect of Endometrial Ablation on Premenstrual Symptoms

Pulsatile LH secretion in women with premenstrual syndrome (PMS): Evidence for normal neuroregulation of the menstrual cycle

Contact Info

Product

Resources

About